Segall Bryant & Hamill, LLC Biogen Inc. Transaction History

Segall Bryant & Hamill, LLC

$7.16 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$275.25 - $318.06 $58,903 - $68,064	-214 Reduced 2.31%	9,051 $2.58 Million
Q1 2023 May 15, 2023	SELL	$256.56 - $292.34 $64,140 - $73,085	-250 Reduced 2.63%	9,265 $2.58 Million
Q4 2022 Feb 14, 2023	BUY	$252.44 - $306.72 $2.4 Million - $2.92 Million	9,515 New	9,515 $2.63 Million
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $1.87 Million - $2.57 Million	9,580 New	9,580 $2.56 Million
Q2 2022 Aug 15, 2022	SELL	$187.54 - $223.02 $16,315 - $19,402	-87 Reduced 0.89%	9,710 $1.98 Million
Q1 2022 May 13, 2022	SELL	$193.77 - $244.14 $1.16 Million - $1.46 Million	-6,000 Reduced 37.98%	9,797 $2.06 Million
Q4 2021 Feb 14, 2022	SELL	$223.92 - $287.77 $49,934 - $64,172	-223 Reduced 1.39%	15,797 $3.79 Million
Q2 2021 Aug 12, 2021	SELL	$259.0 - $414.71 $5,180 - $8,294	-20 Reduced 0.12%	16,020 $5.55 Million
Q1 2021 May 13, 2021	SELL	$242.95 - $284.63 $7,288 - $8,538	-30 Reduced 0.19%	16,040 $4.49 Million
Q3 2020 Nov 13, 2020	BUY	$264.77 - $305.71 $1.68 Million - $1.94 Million	6,330 Added 64.99%	16,070 $4.56 Million
Q2 2020 Aug 14, 2020	SELL	$258.66 - $342.55 $1.63 Million - $2.16 Million	-6,300 Reduced 39.28%	9,740 $2.61 Million
Q1 2020 May 14, 2020	SELL	$268.85 - $341.04 $97,323 - $123,456	-362 Reduced 2.21%	16,040 $5.07 Million
Q4 2019 Feb 11, 2020	SELL	$220.06 - $304.07 $11,003 - $15,203	-50 Reduced 0.3%	16,402 $4.87 Million
Q3 2019 Nov 12, 2019	SELL	$217.44 - $243.88 $17,395 - $19,510	-80 Reduced 0.48%	16,452 $3.83 Million
Q2 2019 Aug 14, 2019	BUY	$219.29 - $241.72 $446,693 - $492,383	2,037 Added 14.05%	16,532 $0
Q1 2019 May 15, 2019	SELL	$216.71 - $338.96 $35,757 - $55,928	-165 Reduced 1.13%	14,495 $0
Q4 2018 Feb 15, 2019	SELL	$278.5 - $352.75 $33,141 - $41,977	-119 Reduced 0.81%	14,660 $4.41 Million
Q3 2018 Nov 14, 2018	SELL	$293.51 - $383.83 $13,501 - $17,656	-46 Reduced 0.31%	14,779 $0
Q2 2018 Aug 08, 2018	BUY	$257.52 - $306.91 $74,938 - $89,310	291 Added 2.0%	14,825 $0
Q4 2017 Feb 15, 2018	SELL	$307.64 - $344.58 $183,353 - $205,369	-596 Reduced 3.94%	14,534 $0
Q3 2017 Nov 14, 2017	BUY	$281.15 - $329.69 $4.25 Million - $4.99 Million	15,130	15,130 $0

Others Institutions Holding BIIB

# of Institutions

1,006

Shares Held

129M

Call Options Held

1.12M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Segall Bryant & Hamill, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Segall Bryant & Hamill, LLC with notifications on news.

Account